CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+14.98%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$787M
AUM Growth
+$787M
(+53%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
29.03%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
459
New
34
Increased
332
Reduced
39
Closed
19
Top Buys
| 1 |
Microsoft
MSFT
|
$18.2M |
| 2 |
NVIDIA
NVDA
|
$11.9M |
| 3 |
Netflix
NFLX
|
$9.94M |
| 4 |
Amazon
AMZN
|
$7.89M |
| 5 |
Meta Platforms (Facebook)
META
|
$7.84M |
Top Sells
| 1 |
Vanguard World Funds Extended Duration ETF
EDV
|
$3.64M |
| 2 |
Alibaba
BABA
|
$2.59M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$2.4M |
| 4 |
Intel
INTC
|
$2.07M |
| 5 |
Coca-Cola
KO
|
$1.91M |
Sector Composition
| 1 | Technology | 37.36% |
| 2 | Healthcare | 29.98% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Communication Services | 8.97% |
| 5 | Financials | 3.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Vaxcyte
PCVX
$4B
| $1.42M | 0.18% |
20,840
-21,327
| -51% | -$1.46M |
|
102
Zillow
Z
$20.4B
| $1.41M | 0.18% |
+28,855
| New | +$1.41M |
|
103
Academy Sports + Outdoors
ASO
$3.56B
| $1.39M | 0.18% |
20,622
-7,282
| -26% | -$493K |
|
104
Cytokinetics
CYTK
$4.23B
| $1.39M | 0.18% |
19,770
+8,429
| +74% | +$591K |
|
105
Exelixis
EXEL
$10.1B
| $1.38M | 0.18% |
58,299
+22,324
| +62% | +$530K |
|
106
Apellis Pharmaceuticals
APLS
$3.48B
| $1.36M | 0.17% |
23,182
+9,472
| +69% | +$557K |
|
107
Cisco
CSCO
$274B
| $1.32M | 0.17% |
26,423
+18,339
| +227% | +$915K |
|
108
Ferrari
RACE
$85B
| $1.31M | 0.17% |
3,007
-1,175
| -28% | -$512K |
|
|
ITCI
109
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.29M | 0.16% |
18,613
+7,480
| +67% | +$518K |
|
|
ONC
110
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.25M | 0.16% |
7,991
+3,135
| +65% | +$490K |
|
|
111
Intel
INTC
$107B
| $1.22M | 0.15% |
27,536
-46,784
| -63% | -$2.07M |
|
112
Ionis Pharmaceuticals
IONS
$6.79B
| $1.21M | 0.15% |
28,027
+11,429
| +69% | +$495K |
|
113
Coherent
COHR
$14.1B
| $1.21M | 0.15% |
+20,000
| New | +$1.21M |
|
114
Polaris
PII
$3.18B
| $1.21M | 0.15% |
12,075
-6,794
| -36% | -$680K |
|
115
Intuit
INTU
$186B
| $1.19M | 0.15% |
1,825
+1,269
| +228% | +$825K |
|
116
JPMorgan Chase
JPM
$829B
| $1.18M | 0.15% |
+5,914
| New | +$1.18M |
|
117
Kanzhun
BZ
$10.8B
| $1.14M | 0.14% |
+65,000
| New | +$1.14M |
|
118
Wayfair
W
$9.67B
| $1.13M | 0.14% |
+16,580
| New | +$1.13M |
|
119
Comcast
CMCSA
$125B
| $1.12M | 0.14% |
25,935
+17,928
| +224% | +$777K |
|
|
BPMC
120
DELISTED
Blueprint Medicines
BPMC
| $1.12M | 0.14% |
11,777
+4,745
| +67% | +$450K |
|
121
Applied Materials
AMAT
$128B
| $1.12M | 0.14% |
5,417
+3,765
| +228% | +$776K |
|
122
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.11M | 0.14% |
+2,632
| New | +$1.11M |
|
123
Hilton Worldwide
HLT
$64.9B
| $1.06M | 0.13% |
4,964
+1,842
| +59% | +$393K |
|
124
CRISPR Therapeutics
CRSP
$4.71B
| $1.05M | 0.13% |
15,409
+6,216
| +68% | +$424K |
|
125
BridgeBio Pharma
BBIO
$9.89B
| $1.04M | 0.13% |
33,774
+13,654
| +68% | +$422K |
|